Checchi Capital Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.02M | Sell |
19,940
-446
| -2% | -$96K | 0.23% | 79 |
|
|
2026
Q1 | $4.43M | Buy |
20,386
+645
| +3% | +$143K | 0.22% | 76 |
|
|
2025
Q4 | $4.51M | Sell |
19,741
-130
| -0.7% | -$29.6K | 0.23% | 74 |
|
|
2025
Q3 | $4.6M | Sell |
19,871
-1,484
| -7% | -$302K | 0.24% | 75 |
|
|
2025
Q2 | $3.96M | Sell |
21,355
-2,492
| -10% | -$463K | 0.22% | 86 |
|
|
2025
Q1 | $5M | Buy |
23,847
+494
| +2% | +$96K | 0.26% | 70 |
|
|
2024
Q4 | $4.15M | Buy |
23,353
+61
| +0.3% | +$11.2K | 0.24% | 80 |
|
|
2024
Q3 | $4.6M | Buy |
23,292
+677
| +3% | +$126K | 0.26% | 70 |
|
|
2024
Q2 | $3.88M | Sell |
22,615
-36
| -0.2% | -$5.96K | 0.19% | 72 |
|
|
2024
Q1 | $4.12M | Buy |
22,651
+135
| +0.6% | +$23.3K | 0.32% | 74 |
|
|
2023
Q4 | $3.49M | Sell |
22,516
-703
| -3% | -$102K | 0.28% | 76 |
|
|
2023
Q3 | $3.46M | Buy |
23,219
+294
| +1% | +$43.2K | 0.32% | 72 |
|
|
2023
Q2 | $3.09M | Sell |
22,925
-558
| -2% | -$81.8K | 0.28% | 80 |
|
|
2023
Q1 | $3.74M | Buy |
23,483
+531
| +2% | +$81.2K | 0.36% | 63 |
|
|
2022
Q4 | $3.71M | Sell |
22,952
-1,435
| -6% | -$220K | 0.39% | 64 |
|
|
2022
Q3 | $3.27M | Buy |
24,387
+282
| +1% | +$40.5K | 0.31% | 75 |
|
|
2022
Q2 | $3.46M | Buy |
24,105
+3,005
| +14% | +$459K | 0.3% | 72 |
|
|
2022
Q1 | $3.42M | Buy |
21,100
+2,425
| +13% | +$352K | 0.29% | 64 |
|
|
2021
Q4 | $2.53M | Buy |
18,675
+247
| +1% | +$29.2K | 0.22% | 74 |
|
|
2021
Q3 | $1.99M | Sell |
18,428
-446
| -2% | -$51K | 0.2% | 89 |
|
|
2021
Q2 | $2.13M | Sell |
18,874
-230
| -1% | -$25.9K | 0.21% | 89 |
|
|
2021
Q1 | $2.07M | Sell |
19,104
-659
| -3% | -$70.5K | 0.2% | 89 |
|
|
2020
Q4 | $2.12M | Sell |
19,763
-2,579
| -12% | -$248K | 0.22% | 84 |
|
|
2020
Q3 | $1.96M | Sell |
22,342
-2,215
| -9% | -$209K | 0.22% | 75 |
|
|
2020
Q2 | $2.41M | Buy |
24,557
+2,814
| +13% | +$248K | 0.29% | 53 |
|
|
2020
Q1 | $1.66M | Buy |
21,743
+1,033
| +5% | +$88K | 0.16% | 69 |
|
|
2019
Q4 | $1.83M | Buy |
20,710
+3,484
| +20% | +$289K | 0.25% | 70 |
|
|
2019
Q3 | $1.3M | Hold |
17,226
| – | – | 0.17% | 81 |
|
|
2019
Q2 | $1.25M | Buy |
17,226
+1,606
| +10% | +$126K | 0.16% | 85 |
|
|
2019
Q1 | $1.26M | Sell |
15,620
-1,261
| -7% | -$103K | 0.15% | 84 |
|
|
2018
Q4 | $1.56M | Sell |
16,881
-2,557
| -13% | -$225K | 0.2% | 69 |
|
|
2018
Q3 | $1.84M | Buy |
19,438
+276
| +1% | +$26.2K | 0.21% | 67 |
|
|
2018
Q2 | $1.77M | Buy |
19,162
+402
| +2% | +$39.3K | 0.22% | 64 |
|
|
2018
Q1 | $1.78M | Buy |
18,760
+222
| +1% | +$24.4K | 0.23% | 65 |
|
|
2017
Q4 | $1.79M | Buy |
18,538
+2,828
| +18% | +$267K | 0.24% | 69 |
|
|
2017
Q3 | $1.4M | Sell |
15,710
-509
| -3% | -$38.7K | 0.14% | 74 |
|
|
2017
Q2 | $1.18M | Sell |
16,219
-2,336
| -13% | -$157K | 0.13% | 81 |
|
|
2017
Q1 | $1.21M | Buy |
18,555
+1,924
| +12% | +$121K | 0.14% | 80 |
|
|
2016
Q4 | $1.04M | Buy |
16,631
+872
| +6% | +$53.2K | 0.14% | 80 |
|
|
2016
Q3 | $994K | Buy |
15,759
+1,102
| +8% | +$71.3K | 0.11% | 85 |
|
|
2016
Q2 | $907K | Buy |
14,657
+722
| +5% | +$44K | 0.1% | 86 |
|
|
2016
Q1 | $796K | Sell |
13,935
-2,092
| -13% | -$117K | 0.18% | 92 |
|
|
2015
Q4 | $949K | Buy |
16,027
+1,324
| +9% | +$76.3K | 0.24% | 87 |
|
|
2015
Q3 | $800K | Buy |
14,703
+832
| +6% | +$54.2K | 0.22% | 88 |
|
|
2015
Q2 | $932K | Sell |
13,871
-52
| -0.4% | -$3.4K | 0.25% | 77 |
|
|
2015
Q1 | $815K | Buy |
13,923
+2,062
| +17% | +$125K | 0.24% | 87 |
|
|
2014
Q4 | $776K | Buy |
11,861
+936
| +9% | +$59K | 0.29% | 77 |
|
|
2014
Q3 | $631K | Buy |
10,925
+3,436
| +46% | +$191K | 0.26% | 84 |
|
|
2014
Q2 | $423K | Buy |
7,489
+1,040
| +16% | +$54.6K | 0.19% | 98 |
|
|
2014
Q1 | $331K | Buy |
6,449
+1,253
| +24% | +$63.3K | 0.2% | 102 |
|
|
2013
Q4 | $274K | Buy |
+5,196
| New | +$255K | 0.21% | 98 |
|
Other funds holding ABBV
Checchi Capital Advisers's ABBV Position: Q2 2026 in Review
Checchi Capital Advisers reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $96K and leaving 19,940 shares worth $5.02M. The position accounts for 0.23% of the portfolio, ranked #79.
Checchi Capital Advisers first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Checchi Capital Advisers held 19,940 shares of AbbVie worth $5.02M as of Q2 2026.
- Checchi Capital Advisers sold 446 AbbVie shares in Q2 2026, an estimated $96K.
- AbbVie made up 0.23% of Checchi Capital Advisers's portfolio in Q2 2026, its #79 holding.
- Checchi Capital Advisers first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.